Song Yongping

[Expert Profile] Song Yongping, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in hematology and hematopoietic stem cell transplantation in China, working at Henan Cancer Hospital. He has long been dedicated to clinical diagnosis, treatment, and scientific research of difficult hematological diseases, hematopoietic stem cell transplantation, and post-transplant complications, and is an important leading figure in hematology in central China.

[Education & Career] Professor Song Yongping graduated from Henan Medical University, completed systematic clinical training at Henan Cancer Hospital, and further studied at famous international hematology and transplantation centers. He has long served as Vice President of Henan Cancer Hospital and Director of the Hematology Department, holding academic positions including member of the Hematology Branch of the Chinese Medical Association and Chair of the Hematology Branch of the Henan Medical Association. He has presided over grants from the National Natural Science Foundation of China and major provincial and ministerial projects, and is a discipline leader in hematology in Henan Province.

[Areas of Expertise] Professor Song specializes in comprehensive treatment of hematologic malignancies such as various leukemias, lymphomas, and multiple myeloma, with particular expertise in hematopoietic stem cell transplantation technology and prevention and treatment of post-transplant complications (graft-versus-host disease, infection, relapse). He has extensive experience in haploidentical transplantation, autologous transplantation, and post-transplant maintenance therapy. He excels at developing transplantation plans for refractory hematology patients who "fail conventional chemotherapy," helping numerous patients achieve long-term disease-free survival.

[Academic Achievements & Industry Contributions] Professor Song has led the establishment of a hematopoietic stem cell transplantation collaboration network covering Henan and surrounding provinces, systematically conducting clinical research on transplantation technology improvement and complication prevention and treatment, with findings published in authoritative domestic and international journals. He has actively promoted the popularization of standardized hematologic oncology diagnosis and treatment and transplantation technology in Henan, led the construction of regional hematology specialty alliances, and organized grassroots physician training and difficult case consultations, significantly improving the overall level of hematology and hematopoietic stem cell transplantation in central China, and making important contributions to regional medical development.

[Clinical Practice & Outstanding Contributions] For decades on the front lines of hematology and transplantation, Professor Song has led his team in completing thousands of hematopoietic stem cell transplants, with transplantation volume ranking among the highest in central China. He has successfully treated numerous difficult hematology patients, bringing hope to countless families. He has been repeatedly recognized as an outstanding discipline leader, and is deeply trusted by patients and respected by peers alike. He is an outstanding expert in the field of hematology and transplantation in central China.

[Honors & Reputation] Professor Song Yongping serves as Vice President of Henan Cancer Hospital and Director of the Henan Institute of Hematology, among other academic positions. He has presided over grants from the National Natural Science Foundation of China and major provincial and ministerial projects, and is an important discipline leader in hematology in central China. He has accumulated extensive experience in the diagnosis and treatment of difficult hematological diseases and post-transplant complications. He has led the establishment of a hematopoietic stem cell transplantation system in Henan, promoted the standardized application of innovative technologies such as CAR-T cell therapy in hematologic malignancies, and participated in the development of multiple hematology diagnosis and treatment guidelines. For decades on the clinical front lines, he has helped numerous difficult hematology patients receive standardized treatment and gain a new lease on life, trained a large number of hematology professionals, and is deeply trusted by patients and respected by peers alike.